Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03373916 · ClinicalTrials.gov registry record · NA

Peer Mentorship to Reduce Suicide Attempts Among High-Risk Adults

A NA study of Suicidal Ideation, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
455
Enrollment target
3
Study locations

NCT03373916 is a NA study of Suicidal Ideation that has completed, run by University of Michigan. The registered enrollment target is 455 participants, above the 262-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (74% higher). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03373916, a NA study of Suicidal Ideation, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
455 participants
Enrollment target
3
Study locations

Study Summary

This is a single-blind, randomized controlled trial to test the effectiveness of a peer mentorship intervention (PREVAIL) for reducing suicide risk compared to enhanced usual care among participants (N=455) at high-risk for suicide recruited from inpatient psychiatric units.

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL Peer mentorship

Study Locations (3)

Michigan

  • University of Michigan Inpatient Psychiatry Unit - Ann Arbor
  • Henry Ford Kingswood Hospital - Ferndale
  • Henry Ford Macomb Hospital - Mount Clemens

Trial Details

FieldValue
Enrollment Target 455 participants
Start Date 2018-06-22
Est. Completion 2023-09-30
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03373916

The ClinicalTrials.gov registry entry for NCT03373916 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 455 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 262-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (74% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT03373916 reports 3 study locations spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03373916 about?

NCT03373916 is a clinical study titled "Peer Mentorship to Reduce Suicide Attempts Among High-Risk Adults". This is a single-blind, randomized controlled trial to test the effectiveness of a peer mentorship intervention (PREVAIL) for reducing suicide risk compared to enhanced usual care among participants (N=455) at high-risk for suicide recruited from inpatient psychiatric units.

What is the current status of trial NCT03373916?

This trial is currently completed. It is a NA study. The enrollment target is 455 participants. The study started on 2018-06-22. Estimated completion is 2023-09-30.

What conditions does trial NCT03373916 study?

This clinical trial studies the following conditions: Suicidal Ideation.

What interventions are being tested in trial NCT03373916?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Peer mentorship (BEHAVIORAL).

Who is sponsoring clinical trial NCT03373916?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03373916 being conducted?

This trial has 3 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.